| Latin Americans n = 99 | Asians n = 72 | Africans n = 50 | Central/eastern Europeans n = 37 | p-value |
---|---|---|---|---|---|
Median age [IQR] | 50 [42, 58] | 51 [36, 59] | 53 [41, 63] | 54 [46, 63] | 0.128 |
Biological sex | Â | Â | Â | Â | Â |
 Female, n (%) | 37 (37) | 17 (24) | 13 (26) | 19 (51) | 0.015 |
 Male, n (%) | 62 (63) | 55 (76) | 37 (74) | 18 (49) |  |
Co-morbidities | Â | Â | Â | Â | Â |
 Obesitya, n (%) | 31 (31) | 10 (14) | 10 (20) | 9 (24) | 0.059 |
 Diabetes, n (%) | 11 (11) | 9 (12) | 8 (16) | 4 (11) | 0.841 |
 Lung diseases, n (%) | 13 (13) | 6 (8) | 8 (16) | 2 (5) | 0.339 |
 Heart diseases, n (%) | 20 (20) | 24 (33) | 19 (38) | 13 (35) | 0.074 |
 Renal diseases, n (%) | 8 (8) | 9 (12) | 3 (6) | 2 (5) | 0.502 |
 Oncological diseases,n (%) | 8 (8) | 5 (7) | 2 (4) | 2 (5) | 0.801 |
 Immune system diseases, n (%) | 10 (10) | 1 (1) | 4 (8) | 4 (11) | 0.137 |
 Liver diseases, n (%) | 6 (6) | 3 (4) | 2 (4) | 2 (5) | 0.929 |
Number of co-morbidities | Â | Â | Â | Â | Â |
 0 | 46 (46) | 34 (47) | 22 (44) | 17 (46) | 0.992 |
 1 | 26 (26) | 19 (26) | 14 (28) | 9 (24) |  |
 2 | 16 (16) | 10 (14) | 7 (14) | 8 (22) |  |
 3 +  | 11 (11) | 9 (12) | 7 (14) | 3 (8) |  |
Median number of days from symptom onset [IQR] | 7 [4, 10] | 6 [2, 8] | 4 [2, 8] | 5 [3, 7] | 0.015 |
Disease severity upon hospital admissionb | Â | Â | Â | Â | Â |
 Mild | 5 (5) | 10 (14) | 9 (18) | 7 (19) | 0.011 |
 Moderate | 39 (39) | 33 (46) | 27 (54) | 14 (38) |  |
 Severe | 30 (30) | 8 (11) | 7 (14) | 9 (24) |  |
 Critical | 25 (25) | 21 (29) | 7 (14) | 7 (19) |  |